Artemis Wealth Advisors’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5
Closed -$3.88K 117
2022
Q2
$3.88K Hold
5
﹤0.01% 107
2022
Q1
$17.9K Hold
5
﹤0.01% 52
2021
Q4
$15.7K Hold
5
﹤0.01% 65
2021
Q3
$33.9K Hold
5
﹤0.01% 60
2021
Q2
$68.6K Hold
5
0.01% 38
2021
Q1
$87.2K Hold
5
0.01% 36
2020
Q4
$87.7K Hold
5
0.01% 32
2020
Q3
$97K Buy
5
+3
+150% +$69K 0.02% 29
2020
Q2
$61.9K Hold
2
0.02% 23
2020
Q1
$51.7K Hold
2
0.02% 22
2019
Q4
$21.7K Hold
2
0.01% 84
2019
Q3
$22.4K Hold
2
0.01% 21
2019
Q2
$37.6K Hold
2
0.02% 17
2019
Q1
$48.7K Hold
2
0.03% 15
2018
Q4
$28.8K Hold
2
0.01% 30
2018
Q3
$58.1K Hold
2
0.03% 15
2018
Q2
$80.8K Buy
2
+1
+100% +$38.4K 0.06% 12
2018
Q1
$51.8K Buy
+1
New +$38K 0.04% 16

Other funds holding KALA

Artemis Wealth Advisors's KALA Position: Q3 2022 in Review

Artemis Wealth Advisors sold out of KALA BIO (KALA) in Q3 2022, closing a stake of 5 shares — an estimated $3.88K sold.

Artemis Wealth Advisors first reported a position in KALA in Q1 2018 and held it in 18 quarters. The position peaked at $97K in Q3 2020. 53 funds tracked by Wall St. Rank hold KALA as of Q3 2022.

  • Artemis Wealth Advisors reported no remaining KALA BIO position as of Q3 2022 after selling out during the quarter.
  • Artemis Wealth Advisors sold 5 KALA BIO shares in Q3 2022, an estimated $3.88K.
  • Artemis Wealth Advisors first reported a position in KALA BIO in Q1 2018 and held it in 18 quarters.
  • Artemis Wealth Advisors's KALA BIO position peaked at $97K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held KALA BIO as of Q3 2022.

Based on Artemis Wealth Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.